These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29395660)

  • 1. New quantitative method for evaluation of motor functions applicable to spinal muscular atrophy.
    Matsumaru N; Hattori R; Ichinomiya T; Tsukamoto K; Kato Z
    Brain Dev; 2018 Mar; 40(3):172-180. PubMed ID: 29395660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
    Nelson L; Owens H; Hynan LS; Iannaccone ST;
    Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy.
    Takeuchi Y; Miyanomae Y; Komatsu H; Oomizono Y; Nishimura A; Okano S; Nishiki T; Sawada T
    J Child Neurol; 1994 Jul; 9(3):287-9. PubMed ID: 7930408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of the thyrotropin-releasing hormone (TRH) analogue, taltireline hydrate, in spinal muscular atrophy.
    Kato Z; Okuda M; Okumura Y; Arai T; Teramoto T; Nishimura M; Kaneko H; Kondo N
    J Child Neurol; 2009 Aug; 24(8):1010-2. PubMed ID: 19666885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art for motor function assessment tools in spinal muscular atrophy (SMA).
    Vuillerot C
    Arch Pediatr; 2020 Dec; 27(7S):7S40-7S44. PubMed ID: 33357597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Questionnaire survey conducted on the parents of patients with spinal muscular atrophy type 1 in Japan regarding switch devices, language development, upper extremity function and QOL].
    Sakai S; Maki M; Sakai N; Sudoh A; Kato M; Saitoh S
    No To Hattatsu; 2012 Nov; 44(6):465-71. PubMed ID: 23240528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measures for pediatric spinal muscular atrophy.
    Iannaccone ST;
    Arch Neurol; 2002 Sep; 59(9):1445-50. PubMed ID: 12223032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy.
    El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP
    Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional motion analysis of arm-reaching movements in healthy and hemispinalized common marmosets.
    Takemi M; Kondo T; Yoshino-Saito K; Sekiguchi T; Kosugi A; Kasuga S; Okano HJ; Okano H; Ushiba J
    Behav Brain Res; 2014 Dec; 275():259-68. PubMed ID: 25245335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper limb evaluation with robotic exoskeleton. Normative values for indices of accuracy, speed and smoothness.
    Merlo A; Longhi M; Giannotti E; Prati P; Giacobbi M; Ruscelli E; Mancini A; Ottaviani M; Montanari L; Mazzoli D
    NeuroRehabilitation; 2013; 33(4):523-30. PubMed ID: 24037096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper limb movements in dementia with Lewy body: a quantitative analysis.
    Fadda L; Corona F; Floris G; Mascia MM; Cossa B; Ercoli T; Pau M; Defazio G
    Exp Brain Res; 2019 Aug; 237(8):2105-2110. PubMed ID: 31177296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirayama disease: oblique amyotrophy and characteristic magnetic resonance imaging findings.
    Tsukita K; Sakamaki-Tsukita H
    QJM; 2018 Aug; 111(8):583-584. PubMed ID: 29518243
    [No Abstract]   [Full Text] [Related]  

  • 19. Motor impairment evaluation for upper limb in stroke patients on the basis of a microsensor.
    Huang S; Luo C; Ye S; Liu F; Xie B; Wang C; Yang L; Huang Z; Wu J
    Int J Rehabil Res; 2012 Jun; 35(2):161-9. PubMed ID: 22470053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).
    Kang PB; Krishnamoorthy KS; Jones RM; Shapiro FD; Darras BT
    Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.